全球非激素避孕产品市场（2023-2030）：按性别（男/女）、产品类型（避孕套/子宫托）和分销渠道（零售药房/医院）划分的规模、份额、增长分析和预测

全球非激素避孕产品市场规模预计将从 2021 年的 271 亿美元增长到 2022 年的 288.6 亿美元，复合年增长率为 6.5%，预计到 2030 年将达到 477.7 亿美元。至1000万美元。

由于人们对非激素避孕产品的认识和采用不断提高，非激素避孕产品的全球市场正在经历显着增长。 非激素避孕方法，例如避孕套、宫内节育器 (IUD)、隔膜以及基于生育意识的方法，提供了副作用较少的替代避孕方法。 人们对激素避孕风险的日益关注、自然避孕方法的趋势以及可用性和负担能力的提高等因素都有助于市场的扩张。 此外，非激素避孕技术的进步和产品开发的创新正在推动市场进一步增长。

全球非激素避孕行业对天然和有机避孕产品的需求正在激增。 消费者意识的提高是由于对激素避孕相关潜在副作用的担忧，导致消费者寻求不含合成激素和化学物质的更安全的替代品。 天然和有机非激素避孕药具，例如避孕套和自然计划生育，由于其安全性和环境友好性而越来越受欢迎。 此外，人们对可持续发展和环境意识的不断增强也推动了向自然避孕的转变。

在本报告中，我们研究了全球非激素避孕产品市场，提供了市场概况，分析了市场上的各种影响因素、技术和创新趋势、市场规模的转变和预测，总结了细分，竞争格局、主要公司概况等

内容

执行摘要

调查方法

母公司市场分析

• 市场概况
• 市场规模
• 市场动态
  • 驱动程序
  • 机会
  • 制约因素
  • 任务

主要市场洞察

• 技术分析
• 价格分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 知识产权分析
• 贸易分析
• 启动分析
• 原材料分析
• 创新矩阵
• 管道产品分析
• 宏观经济指标
• 主要投资分析
• 关键成功因素
• 争用程度

市场动态与展望

• 市场动态
  • 驱动程序
  • 机会
  • 制约因素
  • 任务
• 监管状况
• 波特的分析
• Skyquest 对未来颠覆的特殊洞察

全球非激素避孕产品市场：按性别

• 市场概况
• 男性
• 女性

全球非激素避孕产品市场：按产品类型

• 市场概况
• 安全套
• 子宫托
• 宫颈帽
• 杀精剂
• 避孕海绵

全球非激素避孕产品市场：按分销渠道划分

• 市场概况
• 零售药店
• 医院药房
• 网上药店
• 其他

全球非激素避孕产品市场：按地区

• 市场概况
• 北美
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东和非洲

竞争格局

• 排名前 5 名的公司比较
• 主要公司的市场定位
• 各大公司的招聘策略
• 关键成功策略
• 近期市场活动
• 主要公司的市场份额

主要公司简介

• Bayer AG
• Merck &Co., Inc.
• Allergan
• Cooper Surgical Inc.
• Mayer Laboratories, Inc.
• The Female Health Company
• Agile Therapeutics
• Afaxys, Inc.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Church &Dwight Co., Inc.
• The Population Council, Inc.
• Ansell Ltd.
• Medicines360
• Mylan NV
• Okamoto Industries Inc.
• Reckitt Benckiser Group plc
• V-Care Pharma Pvt. Ltd.
• Fuji Latex Co., Ltd.
• Veru Inc.

Market Insights

Global Non-Hormonal Contraception Market size was valued at USD 27.1 billion in 2021 and is poised to grow from USD 28.86 billion in 2022 to USD 47.77 billion by 2030, growing at a CAGR of 6.5% in the forecast period (2023-2030).

The Global Non-Hormonal Contraception Market is experiencing significant growth due to increasing awareness and adoption of non-hormonal contraceptive methods. Non-hormonal contraceptives, such as condoms, intrauterine devices (IUDs), diaphragms, and fertility awareness-based methods, offer alternatives to hormonal birth control with fewer side effects. Factors such as rising concerns over hormonal contraception risks, preference for natural birth control options, and improved accessibility and affordability contribute to the market expansion. Additionally, advancements in non-hormonal contraceptive technologies and innovations in product development further drive market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of non-hormonal contraception market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Non-Hormonal Contraception Market Segmental Analysis

Global Non-Hormonal Contraception market is segmented by gender, product type, and distribution Channel. Based on gender, the Non-Hormonal Contraception Market can be segmented into male, and female. Based on product type, the Non-Hormonal Contraception Market can be segmented into condoms, diaphragms, cervical caps, spermicides, and contraceptive sponges. Based on distribution channel, the Non-Hormonal Contraception Market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, and others. Based on region, the Non-Hormonal Contraception Market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver

The Non-Hormonal Contraception Market is being driven by the growing awareness about contraception. As more individuals become educated about the various contraceptive options available, there is an increased interest in non-hormonal methods. These alternatives, such as condoms, IUDs, diaphragms, and fertility awareness-based methods, are gaining popularity due to their lower risk of hormonal side effects. Additionally, the preference for natural birth control options and the improvement in accessibility and affordability of non-hormonal contraceptives are contributing to the market's growth. Ongoing advancements and innovations in non-hormonal contraceptive technologies further fuel this positive trend.

Restraints

Constraints in the Non-Hormonal Contraception Market include limited availability and awareness, particularly in developing countries. Access to non-hormonal contraceptive options is often restricted in these regions, leading to a lack of awareness and understanding of the benefits they offer. The focus on traditional contraceptive methods and the limited availability of modern non-hormonal options hinders the widespread adoption of these alternatives. Overcoming these challenges requires targeted efforts to increase availability, education, and awareness about non-hormonal contraceptive methods in developing countries to empower individuals with more choices for family planning.

Market Trends

The global non-hormonal contraception industry is the surging demand for natural and organic contraceptive products. This rising consumer awareness is driven by concerns over potential side effects linked to hormonal contraception, prompting individuals to seek safer alternatives free from synthetic hormones and chemicals. Natural and organic non-hormonal contraceptives, like condoms and natural family planning methods, are gaining popularity due to their perceived safety and eco-friendliness. Furthermore, the increasing emphasis on sustainability and environmental consciousness is fueling the shift towards these nature-based contraceptive options.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Non-Hormonal Contraception Market by Gender

• Market Overview
• Male and Female

Global Non-Hormonal Contraception Market by Product type

• Market Overview
• Condoms
• Diaphragms
• Cervical Caps
• Spermicides
• and Contraceptive Sponges

Global Non-Hormonal Contraception Market by Distribution channel

• Market Overview
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• and Others

Global Non-Hormonal Contraception Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cooper Surgical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayer Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Female Health Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agile Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Afaxys, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Church & Dwight Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Population Council, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ansell Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medicines360
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Okamoto Industries Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• V-Care Pharma Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Latex Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veru Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments